Author: Niklas Mattsson

Unitary SPCs in Europe after all?

As readers of this blog know, we at Awapatent are actively following the exciting developments in the creation of

Read more...

Myriad patent claims on breast cancer genes invalidated by US Supreme Court

In a decision on 13 June, the highest court of the USA, the US Supreme Court, said the final

Read more...

Breast cancer gene patents once again found valid by US appeals court

In the “Myriad case” an ongoing legal battle with many twists and turns, the Court of Appeals for the

Read more...

Focus on China

The fact that China is growing in importance is well known. To Awapatent, this growth is visible in our

Read more...

Supplementary protection for combination products heading for setback at the CJ of the EU

Supplementary protection for combination products heading for setback at the Court of Justice of the EU On 13 July

Read more...

Most comprehensive patent reform in almost 60 years approved by US senate

Most comprehensive patent reform in almost 60 years approved by US senate Historic breakthrough as USA gets to grips

Read more...

BRCA patents in Europe

An ongoing lawsuit in the US has attracted a lot of attention worldwide. The American Civil Liberties Union has,

Read more...

Controversial gene patents finally decided by the EPO

During the last decade, the debate in Europe regarding the patentability of human gene inventions has been heavily influenced

Read more...

USPTO will not give up

Last fall, the US Patent and Trademark Office, USPTO, announced that they would make drastic changes in the rules

Read more...

Mobile Sliding Menu